Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in France

NCT01552005 · clinicaltrials.gov ↗

COMPLETED

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2D)

Interventions

DRUG: Saxagliptin

Sponsor

AstraZeneca